These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30539079)

  • 1. Simple Resistance Exercise for 24 Weeks Decreases Alanine Aminotransferase Levels in Patients with Non-Alcoholic Fatty Liver Disease.
    Takahashi A; Imaizumi H; Hayashi M; Okai K; Abe K; Usami K; Tanji N; Ohira H
    Sports Med Int Open; 2017 Jan; 1(1):E2-E7. PubMed ID: 30539079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple resistance exercise decreases cytokeratin 18 and fibroblast growth factor 21 levels in patients with nonalcoholic fatty liver disease: A retrospective clinical study.
    Takahashi A; Abe K; Fujita M; Hayashi M; Okai K; Ohira H
    Medicine (Baltimore); 2020 May; 99(22):e20399. PubMed ID: 32481431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple Resistance Exercise helps Patients with Non-alcoholic Fatty Liver Disease.
    Takahashi A; Abe K; Usami K; Imaizumi H; Hayashi M; Okai K; Kanno Y; Tanji N; Watanabe H; Ohira H
    Int J Sports Med; 2015 Oct; 36(10):848-52. PubMed ID: 26090879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD: a pilot study.
    Kawaguchi T; Shiba N; Maeda T; Matsugaki T; Takano Y; Itou M; Sakata M; Taniguchi E; Nagata K; Sata M
    J Gastroenterol; 2011 Jun; 46(6):746-57. PubMed ID: 21340530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of aerobic exercise and resistance exercise in improving non-alcoholic fatty liver disease: a randomized controlled trial].
    Jia GY; Han T; Gao L; Wang L; Wang SC; Yang L; Zhang J; Guan YY; Yan NN; Yu HY; Xiao HJ; Di FS
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):34-41. PubMed ID: 29804360
    [No Abstract]   [Full Text] [Related]  

  • 6. Weight reduction improves markers of hepatic function and insulin resistance in type-2 diabetic patients with non-alcoholic fatty liver.
    Al-Jiffri O; Al-Sharif FM; Abd El-Kader SM; Ashmawy EM
    Afr Health Sci; 2013 Sep; 13(3):667-72. PubMed ID: 24250305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Chinese Medicinal Formula BNG-1 on Phosphodiesterase 3B Expression, Hepatic Steatosis, and Insulin Resistance in High Fat Diet-induced NAFLD Mice.
    Guo CH; Chen WL; Liao CH; Huang K; Chen PY; Yang CP
    Int J Med Sci; 2018; 15(11):1194-1202. PubMed ID: 30123057
    [No Abstract]   [Full Text] [Related]  

  • 8. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
    Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
    Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease.
    Cuthbertson DJ; Shojaee-Moradie F; Sprung VS; Jones H; Pugh CJ; Richardson P; Kemp GJ; Barrett M; Jackson NC; Thomas EL; Bell JD; Umpleby AM
    Clin Sci (Lond); 2016 Jan; 130(2):93-104. PubMed ID: 26424731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
    Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
    Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
    Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
    Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Chehrehgosha H; Sohrabi MR; Ismail-Beigi F; Malek M; Reza Babaei M; Zamani F; Ajdarkosh H; Khoonsari M; Fallah AE; Khamseh ME
    Diabetes Ther; 2021 Mar; 12(3):843-861. PubMed ID: 33586120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Symptoms of Gastroesophageal Reflux Disease Correlate with High Body Mass Index, the Aspartate Aminotransferase/Alanine Aminotransferase Ratio and Insulin Resistance in Japanese Patients with Non-alcoholic Fatty Liver Disease.
    Fujiwara M; Eguchi Y; Fukumori N; Eguchi H; Tomonaga M; Yoshioka T; Hyakutake M; Sakanishi Y; Kyoraku I; Sugioka T; Fujimoto K; Kusano M; Yamashita S
    Intern Med; 2015; 54(24):3099-104. PubMed ID: 26666594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Life style modification improves insulin resistance and liver histology in patients with non-alcoholic fatty liver disease.
    Bhat G; Baba CS; Pandey A; Kumari N; Choudhuri G
    World J Hepatol; 2012 Jul; 4(7):209-17. PubMed ID: 22855696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Aerobic Exercise Alone or in Conjunction With Diet on Liver Function, Insulin Resistance and Lipids in Non-Alcoholic Fatty Liver Disease.
    Mohammad Rahimi GR; Attarzadeh Hosseini SR
    Biol Res Nurs; 2022 Apr; 24(2):259-276. PubMed ID: 35130757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.
    Wong VW; Wong GL; Chan RS; Shu SS; Cheung BH; Li LS; Chim AM; Chan CK; Leung JK; Chu WC; Woo J; Chan HL
    J Hepatol; 2018 Dec; 69(6):1349-1356. PubMed ID: 30142427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Metformin on Aminotransferase Levels, Metabolic Parameters and Body Mass Index in Nonalcoholic Fatty Liver Disease Patients: A Metaanalysis.
    Hu H; Wang J; Li X; Shen L; Shi D; Meng J
    Curr Pharm Des; 2021; 27(29):3235-3243. PubMed ID: 33719959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of aerobic, resistance, and combined training on PPAR-α, SIRT1 gene expression, and insulin resistance in high-fat diet-induced NAFLD male rats.
    Nikroo H; Hosseini SRA; Fathi M; Sardar MA; Khazaei M
    Physiol Behav; 2020 Dec; 227():113149. PubMed ID: 32888948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 'donations for decreased ALT (D4D)' prosocial behavior incentive scheme for NAFLD patients.
    Sumida Y; Yoshikawa T; Tanaka S; Taketani H; Kanemasa K; Nishimura T; Yamaguchi K; Mitsuyoshi H; Yasui K; Minami M; Naito Y; Itoh Y
    J Public Health (Oxf); 2014 Dec; 36(4):629-34. PubMed ID: 24099735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys: A Randomized Clinical Trial.
    Schwimmer JB; Ugalde-Nicalo P; Welsh JA; Angeles JE; Cordero M; Harlow KE; Alazraki A; Durelle J; Knight-Scott J; Newton KP; Cleeton R; Knott C; Konomi J; Middleton MS; Travers C; Sirlin CB; Hernandez A; Sekkarie A; McCracken C; Vos MB
    JAMA; 2019 Jan; 321(3):256-265. PubMed ID: 30667502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.